REDUCING HOSPITAL STAY IN CHILDREN WITH DIABETIC KETOACIDOSIS

Diabetic ketoacidosis is a major cause of morbidity and mortality in patients with type 1 diabetes mellitus. The cost of its treatment in ICU is significant. Low-dose continuous insulin infusion is the standard regimen for correction of hyperglycemia and acidosis. We used subcutaneous insulin glargine along with intravenous regular insulin in our stable DKA patients. The results were encouraging, our patients had a smooth glycemic control and required less hospital stay. This intervention resulted in better outcome and less economic burden to our patient's family.